Compare · DXCM vs VTAK
DXCM vs VTAK
Side-by-side comparison of DexCom Inc. (DXCM) and Catheter Precision Inc. (VTAK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and VTAK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $31.65B, about 9426.0x VTAK ($3.4M).
- Over the past year, DXCM is up 10.4% and VTAK is down 93.1% - DXCM leads by 103.5 points.
- DXCM has been more active in the news (8 items in the past 4 weeks vs 7 for VTAK).
- DXCM has more recent analyst coverage (25 ratings vs 0 for VTAK).
- Company
- DexCom Inc.
- Catheter Precision Inc.
- Price
- $83.89-0.70%
- $0.17-11.54%
- Market cap
- $31.65B
- $3.4M
- 1M return
- -4.28%
- -42.72%
- 1Y return
- +10.40%
- -93.10%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- AMEX
- IPO
- 2005
- 2018
- News (4w)
- 8
- 7
- Recent ratings
- 25
- 0
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Latest DXCM
- Dexcom Announces Upcoming Conference Presentation
- EVP Chief People & Culture Off Stern Sadie sold $226,669 worth of shares (2,565 units at $88.37) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 126,043 units (SEC Form 4)
- EVP Chief Legal Compliance Off Brown Michael Jon covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 101,502 units (SEC Form 4) (withholding obligation)
- EVP, Chief Financal Officer Sylvain Jereme M covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.96% to 150,390 units (SEC Form 4) (withholding tax)
- President, CEO, and Director Leach Jacob Steven covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.35% to 418,908 units (SEC Form 4) to satisfy withholding tax
- EVP Chief People & Culture Off Stern Sadie covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 128,608 units (SEC Form 4) (withholding tax)
- Executive Chair Sayer Kevin R sold $2,408,242 worth of shares (26,756 units at $90.01) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 302,214 units (SEC Form 4)
- EVP Chief Legal Compliance Off Brown Michael Jon sold $156,281 worth of shares (1,700 units at $91.93) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 102,953 units (SEC Form 4)
- Director Augustinos Nicholas gifted 1,075 shares (SEC Form 4)
- Director Heller Bridgette P sold $89,349 worth of shares (1,012 units at $88.29) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 29,570 units (SEC Form 4)
Latest VTAK
- Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
- SEC Form DEF 14A filed by Catheter Precision Inc.
- Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
- SEC Form 424B3 filed by Catheter Precision Inc.
- SEC Form PRE 14A filed by Catheter Precision Inc.
- Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
- Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market
- SEC Form 10-Q filed by Catheter Precision Inc.
- Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event
- Flyte Achieves Record Revenues in July